title: [De-escalation and atypical antipsychotics in the treatment of acute mania].
abstract: Agitation is a severe clinical state which represents a therapeutic challenge and often forms part of manic or mixed episodes. Therapeutic options for acute mania have been limited for many years to lithium and typical antipsychotics. Besides anticonvulsants, atypical antipsychotics have been increasingly introduced in the last decade after proving their efficacy in this indication. To avoid intramuscular administration and excessive sedation, a therapeutic contact to the often agitated patient is required. De-escalation techniques can be helpful in this respect but also reduce aggressive behaviour on the ward, improve compliance, reduce relapse rates and lead to a better outcome in the long-term course of the illness. Therefore, a basic knowledge about de-escalation techniques in acute manic patients is an important clinical tool which will be critically reviewed. Furthermore, the efficacy and tolerability of atypical antipsychotics in acute mania, such as olanzapine, zotepine, risperidone, quetiapine, ziprasidone, aripiprazole, paliperidone and asenapine are discussed.
authors.affiliation: FIDMAG Research Foundation, Germanes Hospitalàries, Barcelona, Spain. benedikt.amann@gmail.com
authors.forename: B L
authors.initials: BL
authors.lastname: Amann
authors.forename: R
authors.initials: R
authors.lastname: Wesuls
authors.forename: R
authors.initials: R
authors.lastname: Landin Romero
authors.forename: H
authors.initials: H
authors.lastname: Grunze
mesh_terms: D018692:Antimanic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D006801:Humans
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents